BRIEF — Verastem's Daniel Paterson To Retire As President And CEO, Will Remain As Advisor And Board Member

Oct 14 (Reuters) — Verastem Inc: Verastem Oncology Announces Planned Chief Executive Officer Transition And Succession Plan Verastem - Daniel Paterson To Retire As President And Ceo, Will Remain As Advisor And Board Member Verastem - Appoints Michael P. Bailey As President And Ceo Effective January 1, 2027 Source text:... Further company coverage: VSTM.O (Reuters.Briefs@thomsonreuters.com;)